0001102624-13-000218.txt : 20130220
0001102624-13-000218.hdr.sgml : 20130220
20130220180539
ACCESSION NUMBER: 0001102624-13-000218
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130219
FILED AS OF DATE: 20130220
DATE AS OF CHANGE: 20130220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krivulka Joseph J
CENTRAL INDEX KEY: 0001296750
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50481
FILM NUMBER: 13628144
MAIL ADDRESS:
STREET 1: 110 ALLEN ROAD
CITY: LIBERTY CORNER
STATE: NJ
ZIP: 07938
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEOLUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001261734
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 561953785
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26361 CROWN VALLEY PARKWAY, SUITE 150
CITY: MISSION VIEJO
STATE: CA
ZIP: 92691
BUSINESS PHONE: 9494819825
MAIL ADDRESS:
STREET 1: 26361 CROWN VALLEY PARKWAY, SUITE 150
CITY: MISSION VIEJO
STATE: CA
ZIP: 92691
FORMER COMPANY:
FORMER CONFORMED NAME: INCARA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20031205
FORMER COMPANY:
FORMER CONFORMED NAME: INCARA INC
DATE OF NAME CHANGE: 20030828
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-02-19
0
0001261734
AEOLUS PHARMACEUTICALS, INC.
AOLS
0001296750
Krivulka Joseph J
C/O AEOLUS PHARMACEUTICALS, INC.
26361 CROWN VALLEY PARKWAY, INC. STE 150
MISSION VIEJO
CA
92691
1
0
0
0
Common Stock, $0.01 par value per share
2013-02-19
4
P
0
400000
A
733333
D
Warrants (right to buy)
0.25
2013-02-19
4
P
0
400000
A
2013-02-19
2018-02-19
Common Stock
400000
400000
D
(1) Pursuant to a Securities Purchase Agreement by and between Aeolus Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Mr. Krivulka, dated as of February 19, 2013, the Company issued and sold 400,000 Units (the "Units") to Mr. Krivulka for a purchase price of $100,000. Each Unit is comprised of one (1) share of the Company's common stock, $0.01 par value per share (the "Common Stock"), and one (1) warrant to purchase one (1) share of Common Stock with an initial exercise price of $0.25 per share of Common Stock, subject to certain adjustments.
/s/ John L. McManus, by power of attorney
2013-02-20